Latest Industry Insights

Bruker Corporation officially opened its new production facility in Bremen – one of Germany’s major science hubs – last week. Technology Networks visited the facility to learn about its low carbon footprint and how it will support Bruker's commitment to innovation and collaboration.

At ELRIG’s Research and Innovation 2024 event, Technology Networks spoke with A4Cell to learn about its SPAchip® technology, which consists of intracellular silicon microchips that monitor cellular pathways in real time.

Sarah Cotts tells us more about the Rheo-Impedance accessory and how it can help overcome limitations with current analysis approaches to improve battery development.

Michelle C. Werner discusses how tRNAs could transform the drug development paradigm from gene-centric to gene-agnostic and accelerate new therapies for 30 million or more patients whose genetically driven disease can be classified under Stop Codon Disease.

While in vitro tests and animal models can give some indication of potential drug safety issues, they do not always translate well to humans. Ignota Labs is tackling this challenge.

In this interview, Jeroen Verheyen tells us about Semarion, its SemaCyte technology and how it can help to address unmet drug screening needs.

In this interview, Technology Networks spoke to Karim Aly, CEO of Noze to find out more about replicating human odor perception and the benefits of breath-based disease detection.

Until recently, a lack of specialized services meant there was no definitive method for safely and effectively decontaminating plastic waste for reuse in new consumables. As a result, this waste was incinerated or diverted to landfill. The start-up company LabCycle has tackled this issue head-on, with its innovative approach to laboratory waste management. Technology Networks recently had the pleasure of speaking with LabCycle’s co-founder and chief technology officer Dr. Helen Liang, to learn more about its circular economy for laboratory plastic waste.

Neil Ward tells us about the role that genomics can play in conserving biodiversity and how innovative technologies such as HiFi sequencing are helping biodiversity projects.

We interview Raffaello Sbordoni, research scientist at Revivocell, to dive deeper into how high-complexity in vitromodels are supporting pharmaceutical development and their future potential.